Care has become very complex and it isn’t enough to just give patients information and hope they can process it on their own, said Barbara Tofani, RN, MSN, NEA-BC, administrative director of the Hunterdon Regional Cancer Center.
Care has become very complex and it isn’t enough to just give patients information and hope they can process it on their own, said Barbara Tofani, RN, MSN, NEA-BC, administrative director of the Hunterdon Regional Cancer Center.
Transcript
Why is care coordination in the United States not at the level it should be? Why do we still have so much to improve in this area?
I think we need to improve because I think we really underestimated the need for care coordination. And patients are being hit with so much information and there was a time that we thought if we just gave them the information they’d be great, and now what we’re realizing is that we’ve given them so much information it’s almost the equivalent of giving them no information at all. Because they just can’t read it, they can’t process it, they can’t deal with it. I think we underestimated that problem.
It used to be that patients were kind of a captive audience for us—at least in oncology. They came into the hospital, we gave their treatment or they came into the outpatient centers, the private practices, and we gave them their treatment and they went on their way. Now, easily half of the patients are getting oral chemotherapy agents—we’re just writing a script for them and we’re sending them home, and really nobody has been paying attention to: can they afford it, are they taking it, are they taking the medication correctly, how are they dealing with the side effects, do they even know what side effects to be looking for?
I think the care has become very complex. We thought the solution was going to be just educate them, and we’re finding that’s not been the solution at all. It’s almost like we’re back to square 1 again. And we’ve really got to start all over and figure out how to get patients the right resources and the right attention at the right time in the right doses, for want of a better way to put it.
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, that has been made in the fight against the HIV pandemic given the current political climate.
Read More
HIVconsvX Vaccine Shows Safety, Immune Response in People on ART
March 10th 2025This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Read More